Insights On Trial Design

  1. 3 Ways Clinical Trial Diversity Can Put Sponsors On Top 11/20/2023

    Get an overview of sponsors' ongoing challenges regarding diversity in clinical trials and the innovative ways they are striving to overcome them.

  2. Insights From Pharma 2025: Elevating Patient Engagement 6/12/2025

    A significant gap exists between drug development and patient use. Industry veteran Mark Duman explains why listening to patients is the key to closing it and improving health outcomes.

  3. Why EHR Data Is The Game Changer For Life Sciences Success 5/26/2025

    The pharmaceutical industry faces soaring costs and shrinking ROI. Discover why leveraging rich real-world data is now essential for driving efficiency, innovation, and competitive advantage.

  4. Deal-Making Volume Slowed In 2023 5/15/2024

    This report provides an overview of alliance, merger and acquisition, and financing deal activities across the global biopharma, medical device, and in vitro diagnostics industries in 2023, as reported by Biomedtracker.

  5. Evaluating Adaptive Trials: Do They Align With Your Study's Goals? 4/10/2025

    In this short video as Robin Bliss, Vice President, Strategic Consulting at Veristat, shares four key questions that she likes to ask when planning an adaptive design clinical trial.

  6. Pathway To Success: How De-Risking Life Sciences Companies Leads To Investment Growth 3/7/2025

    De-risking in clinical development is essential to optimizing trial success and ensuring regulatory approval and strategic decision-making at critical points in a study’s lifecycle can minimize uncertainties.

  7. Tips And Tricks For Developing Rare Cancer Clinical Trials 2/6/2025

    Conducting clinical trials for rare cancers presents unique challenges, making a partnership with an experienced Oncology CRO crucial for overcoming hurdles and ensuring trial success.

  8. Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 Study 1/6/2025

    Explore the success story of an early-stage clinical pharmaceutical company that effectively navigated funding constraints when conducting its Phase 1 study without a third-party CRO. 

  9. Navigating The Complex World Of First In Human Oncology Trials 5/6/2025

    First-in-human oncology trials are critical touchpoints in the development of novel cancer therapies, requiring precise scientific execution and a deeply patient-centric approach.

  10. ICH E9(R1) Addendum On Estimands And Sensitivity Analysis 7/23/2024

    Discover how the new framework will improve the way of designing and planning clinical trials and performing primary analyses and sensitivity analyses.